Our Story

Simon Wilkins

Head of Operations - Melbourne

Simon joined Brandon Capital Partners in 2021.

Prior to joining, Simon worked as a Venture Creator within the New Ventures team as part of the University of Melbourne’s Research Innovation & Commercialisation (RIC) group. He has 20+ years of experience in research commercialisation, business development and technology advisory, and has variously worked in Biotech/Pharma, strategy consulting to the innovation & technology sector, as well as in biomedical research and technology commercialisation.

In 2016 he co-founded Translating Research at Melbourne (TRAM) as a cohort-based experiential program to develop the entrepreneurial capability and practical business skills of researchers at the University of Melbourne (now part of the Melbourne Entrepreneurial Centre within the Melbourne Connect innovation precinct) and served as founding Director. TRAM has now trained over 300 researchers, attracted over $6M in investment and accelerated the establishment of 9 research-based startups. Simon brings a passion for innovation and community building, and a practical, “can do” approach to solving the challenges around early-stage venture craft, industry collaboration and precinct development.

Simon holds a number of commercial advisory roles at the intersection of digital technology and the health sector, as well as formal qualifications in biomedical research and applied finance. He is also a graduate of the AICD Company Director’s course.

Simon serves on the Board of Directors for Knowledge Commercialisation Australasia (KCA), the peak body leading best practice in industry engagement, commercialisation and entrepreneurship for research organisations. He is also an Associate Professor (Adjunct) with the Melbourne Business School, where he co-delivers the award-winning BioDesign Innovation course to Masters of Engineering and Business School students to develop their entrepreneurial capabilities in solving unmet clinical needs through the development of new medical technologies.